Company news
Evolent Health, Inc (NYSE:EVH) news
Every Evolent Health, Inc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
July 8, 2026
Evolent Announces First Quarter 2026 Results
May 7, 2026
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
April 7, 2026
Evolent announces appointment of Archie Mayani as chief product officer
March 19, 2026
Evolent to Participate in Upcoming Investor Conferences
February 26, 2026
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
February 24, 2026
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
February 4, 2026
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
January 2, 2026
Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
November 6, 2025
Evolent Announces Third Quarter 2025 Results
November 6, 2025
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
October 9, 2025
Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
September 23, 2025
[solidcore] Adds New Leadership and Board Expertise Amid Strong Growth
September 9, 2025
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Ex...
August 19, 2025
Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and ...
August 18, 2025
Evolent Announces Second Quarter 2025 Results
August 7, 2025
Ashley Snyder Joins Medical Home Network as Chief Development Officer to Lead Partnership Efforts
July 23, 2025
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
July 14, 2025
Evolent announces key appointments to leadership team
July 9, 2025
Evolent reiterates Q2 and full year guidance for Adjusted EBITDA
June 20, 2025
Evolent Announces First Quarter 2025 Results
May 8, 2025
Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors
April 22, 2025
Evolent program achieves 20% reduction in use of low-value oncology regimens
April 15, 2025
Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025
April 10, 2025
Evolent Announces Fourth Quarter and Full Year 2024 Results
February 20, 2025